We have reached a historic milestone with the House and Senate passage of the Women and Lung Cancer Research and Preventive Services Act of 2026!After nearly a decade of advocacy, this long-standing legislative priority has earned strong bipartisan and bicameral support,...

In late May, the Office of Management and Budget (OMB) proposed a rule that would significantly change how federal grants and cooperative agreements are awarded, managed, and terminated across the federal government. As written, the proposed rule could allow clinical trials...

In May, Senators Durbin (D-IL) and Hirono (D-HI) introduced S. 4566, the Senate companion to the Increasing Access to Lung Cancer Screening Act (H.R. 6178), reintroduced to this Congress by Representatives Castor (D-FL), Fitzpatrick (R-PA), Wasserman Schultz (D-FL),...

Lung cancer is the leading cause of cancer death, yet federal funding remains far too low. Currently, the Lung Cancer Research Program is funded at $20 million, below FY 2024.  Last year, the Full-Year Continuing Appropriations and Extensions Act (Public Law 119-4) cut...